Chng hot ng bng cch m phng hormone GLP1 t nhin trong c th mt loi hormone c rut tit ra sau khi n, gip iu ha lng ng trong mu v cm gic no
Lets walk through who benefits most, how the transition works, and what to realistically expect
Wittig, R
In advanced stages of clinical review, GLP-1s are also showing promise for treating metabolic dysfunction-associated steatotic liver disease (MASLD), chronic kidney disease (CKD), pre-diabetes, diabetic retinopathy and osteoarthritis of the knee (in patients with obesity)
Bloating and abdominal discomfort can occur because these medicines slow stomach emptying
Understanding your genetic context in these pathways may inform whether your GI side effects are primarily receptor-driven (suggesting timing adjustments might help) or require dose adjustment, medication switching, or supportive strategies